Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Choi, Natalie [1 ]
Choi, David K. [1 ]
Dalal, Sushila [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1141
引用
收藏
页码：S873 / S874
页数：2
相关论文
共 50 条
  • [11] Prospective outcome following ustekinumab treatment in a real-world cohort of inflammatory bowel disease patients
    Lopez, L. Ramos
    Ramos-Diaz, R.
    Benitez-Zafra, F.
    Morant-Dominguez, A.
    Vera-Santana, B.
    Mourani-Padron, I.
    Alonso-Abreu, I.
    Carrillo-Palau, M.
    Reygosa, C.
    Medina-Chico, J. S.
    Gutierrez-Nicolas, F.
    Nazco-Casariego, J.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1587 - I1588
  • [12] Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease--EXVEDOCOL
    Parra, Viviana
    Cifuentes, Sandra
    Avendano, Sandra
    de Leon, Enrique Ponce
    Florez, Cristian
    Reyes, Gustavo
    Puentes, Fabian
    Ballesteros, Manuel
    Nunez, Edilberto
    Gomez, Federico
    Marquez, Juan Ricardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 858 - 866
  • [13] Colombian real-world experience of vedolizumab use in patients with inflammatory bowel disease-EXVEDOCOL
    Parra Izquierdo, V.
    Cifuentes Amortegui, S.
    Avendano R, S.
    Ponce de Leon, E.
    Florez, C.
    Reyes Medina, G.
    Puentes M, F. E.
    Ballesteros B, M.
    Nunez, E. E.
    Hemandez, M.
    Kock, J.
    Marquez, J. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S181 - S182
  • [14] Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Kamble, Pravin
    Wang, Song
    CROHNS & COLITIS 360, 2022, 4 (03)
  • [15] Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease
    Chugh, Rishika
    Braga-Neto, Manuel B.
    Fredrick, Thomas W.
    Ramos, Guilherme P.
    Terdiman, Jonathan
    El-Nachef, Najwa
    Loftus, Edward, V
    Mahadevan, Uma
    Kane, Sunanda, V
    JOURNAL OF CROHNS & COLITIS, 2022, : 504 - 512
  • [16] Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Cleveland, Noa Krugliak
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1913 - +
  • [17] Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
    Jin, Ran
    Nduka, Chidozie
    Courmier, Delphine
    Knight, Hannah
    Meadows, Rachael
    Piercy, James
    Cummings, J. R. F.
    Radziszewski, Waldemar
    ADVANCES IN THERAPY, 2024, 41 (01) : 331 - 348
  • [18] A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
    Lenti, Marco Vincenzo
    Levison, Scott
    Eliadou, Elena
    Willert, Robert
    Kemp, Karen
    Carter, Anna
    Stansfield, Catherine
    Assadsangabi, Arash
    Singh, Salil
    Crooks, Ben
    Tattersall, Suzanne
    Fairhurst, Francesca
    Kenneth, Catherine
    Subramanian, Sreedhar
    Probert, Chris
    Storey, Daniel
    Gregg, Belle
    Smith, Paul
    Liu, Eleanor
    Limdi, Jimmy K.
    Johnston, Alex
    Hamlin, Peter John
    Selinger, Christian P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (12) : 1299 - 1304
  • [19] Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
    Ran Jin
    Chidozie Nduka
    Delphine Courmier
    Hannah Knight
    Rachael Meadows
    James Piercy
    J. R. F. Cummings
    Waldemar Radziszewski
    Advances in Therapy, 2024, 41 : 331 - 348
  • [20] Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
    Lin, Wei-Chen
    Tai, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Shieh, Ming-Jium
    Chung, Chen-Shuan
    Yen, Hsu-Heng
    Chou, Jen-Wei
    Wong, Jau-Min
    Liu, Yu-Hwa
    Huang, Tien-Yu
    Chuang, Chiao-Hsiung
    Tsai, Tzung-Jiun
    Chiang, Feng-Fan
    Lu, Chien-Yu
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Chao, Te-Hsin
    Wu, Deng-Chyang
    Ho, Ai-Sheng
    Lin, Hung-Hsin
    Feng, Chun-Lung
    Wu, Keng-Liang
    Wong, Ming-Wun
    Tung, Chien-Chih
    Lin, Chun-Chi
    Chen, Chia-Chang
    Hu, Huang-Ming
    Lu, Lung-Sheng
    Wang, Huann-Sheng
    Wu, I-Chen
    Kuo, Hsin-Yu
    Wu, Jia-Feng
    Yao Shih, Hsiang
    Ni, Yen-Hsuan
    Tang, Shu-Lun
    Chen, Peng-Hsu
    Wei, Shu-Chen
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1730 - 1740
12345